Unair Realizes National Independence with INAVAC Vaccine
Wednesday, 7 December 2022 12:00 WIB
NATIONAL INFO - Universitas Airlangga participates in overcoming the Covid-19 pandemic through vaccine development. Through a long process, finally the Covid-19 vaccine, which was previously called the Red and White Vaccine, was officially named the INAVAC Vaccine by the President of the Republic of Indonesia Joko Widodo at the end of August 2022. "This vaccine was created in an effort to encourage Unair's significant contribution and impact," said Universitas Airlangga Rector Mohammad Nasih.
The INAVAC vaccine uses
an inactivated virus. That is, the virus has been modified or deactivated so that the virus cannot reproduce itself and cause disease. In the process of making this vaccine, the Food and Drug Supervisory Agency (BPOM) also provides assistance starting from the preclinical trial stage, the 1st to the 3rd clinical trial stage.
Prof. Nasih at the 68th Anniversary of Universitas Airlangga on Wednesday, November 9, 2022, explained that after a long journey, finally the vaccine named INAVAC received an
emergency use authorization (EUA) by BPOM.
EUAs are issued by relevant agencies in a country in an emergency that threatens public health. "INAVAC has received
emergency use authorization by BPOM and will be mass-produced," said Prof. Nasih. This vaccine is used as a prevention of Covid-19 which can be given to individuals aged 18 years and over.
Therefore, the Rector also expressed his gratitude to the various elements who have supported the development of this vaccine. "Thanks to the Ministry of Health for providing support in the form of a lot of funding, the provincial government also provided extraordinary support," he said. "Dr. Soetomo also has tremendous support. Last but not least is the role of Universitas Airlangga researchers who work hard for this."
Acting Director General of Higher Education, Research, and Technology (Diktiristek), Nizam, appreciated what Universitas Airlangga had done through the INAVIC Vaccine. "This is the work of the nation's children through universities, where research and results are very beneficial to the community," said Nizam.
The Directorate General of Higher Education, continued Nizam, always supports universities in producing innovations that are effective for the community in various fields, one of which is the health sector. "The issuance of EUA for the INAVAC Vaccine by Universitas Airlangga, in addition to increasing domestic vaccine stocks, also provides optimism that domestic universities and industries are able to develop their own vaccines. Hopefully, with this vaccine, we can go through the pandemic together," said Nizam.
Nizam also emphasized that the INAVAC Vaccine is a tangible proof of cooperation between universities, industry, and the government to produce real work that benefits the community.
Minister of Health Urges People to Immediately Vaccinate Boosters
The Covid-19 variant that is currently experiencing an increase in positive patients is Omicron XBB. This variant is a genetic mutation of BA.2.10.1 and BA.2.75. Genetic mutations are very common in viruses. This is done by the virus in order to survive.
The Minister of Health (Menkes) of the Republic of Indonesia Budi Gunadi Sadikin during the 68th Anniversary of Universitas Airlangga said that cases with severe symptoms were experienced by someone who had not received the primary or
booster vaccine.
This Omicron XBB variant has various symptoms that can be felt, namely fever or chills, cough, shortness of breath, weakness, muscle aches, headaches, loss of sense of taste or smell, sore throat, runny nose, nausea or vomiting, to diarrhea. Although the severity that occurs due to this variant is not heavier than the Omicron variant, it has a faster spread.
The Minister of Health hopes that the public will remain vigilant and continue to comply with health protocols. In addition, the Minister of Health also advised people who have not received the primary vaccine or secondary vaccine to immediately get the vaccine. Although after giving the vaccine does not guarantee that a person avoids exposure to the Covid-19 virus, giving the vaccine can prevent severity.
"Hospitalization due to Omicron XBB is less than the previous variant. But my advice is to still wear a mask," he said. "Friends who have not been
boostered immediately
booster, who have not been vaccinated are also quick to get vaccinated. For those who have parents and have not received a vaccine or booster, they will immediately be vaccinated or get
a booster. If you are vaccinated, it will reduce the risk of entering the hospital."
For information, the vaccine research and development process will continue. It is expected that after INAVAC there will be other vaccine products produced so that it can answer future challenges and problems. Universitas Airlangga is currently developing a booster vaccine and
a Covid-19 vaccine for children. "The news about the vaccine can be very encouraging, hopefully later
booster vaccines and children can enter," said the Minister of Health.
Meanwhile, efforts to make face-to-face lectures (PTM) successful are limited to the Ministry of Education and Culture by accelerating the development of the INAVAC Vaccine developed by Universitas Airlangga. To maximize
herd immunity, Minister of Education, Culture and Technology Nadiem Makarim asked students to invite other colleagues to take part in vaccinations. "For those who have been vaccinated, spread the message to fellow students about the importance of vaccines," he said.
--------------------------------------------
Indonesia gives emergency use approval to home-grown COVID-19 vaccine Inavac
November 4, 2022
JAKARTA (Reuters) - Indonesia has approved its home-grown coronavirus vaccine Inavac for emergency use, its food and drug agency said on Friday.
The vaccine is the second locally made shot after Indovac, which was approved in September.
(Reporting by Stanley Widianto; Editing by Martin Petty)
Indonesia has approved its home-grown coronavirus vaccine Inavac for emergency use, its food and drug agency said on Friday. The vaccine is the second locally made shot after Indovac, which was approved in September.
news.yahoo.com
